The price drop seems to me to be a natural reaction to the lack of expected info on a catalyst along with in-the-money options nearing an expiration date.
Delays usually punish a stock, especially with a pre-revenue company where time is literally money. I wondered if something was up in June with the two press releases about the FIH trial. While it's always good to know that the DurAVR is performing, those press releases were not essential and IMO were probably just intended to fill the space left by a delayed EFS announcement. We'll see if Anteris tries to fill the gap again with another non-essential PR or, if not, I expect an upcoming announcement about the EFS.
Price, page-9
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |